ClinicalTrials.Veeva

Menu

Radiofrequency-assisted Transection of the Pancreas vs Stapler (TRANSPAIRE)

P

Patricia Sanchez Velazquez

Status

Enrolling

Conditions

Pancreas; Fistula

Treatments

Procedure: Stapler assisted pancreas transection
Procedure: Radiofrequency-assisted pancreas transection

Study type

Interventional

Funder types

Other

Identifiers

NCT04402346
HMar_RF_transection_pancreas

Details and patient eligibility

About

Main objective: The main end-point of this study is to compare in a randomized clinical trial that radiofrequency-assisted pancreas transection (RF) reduces the incidence of postoperative pancreatic fistula (POPF) compared to the classical method of transection (stapler). As secondary end-points, other clinical and demographic variables of the patients will be evaluated (sex, age, ASA classification, consistency of the pancreas, as well as the type of procedure, open or laparoscopic surgery, estimated intraoperative bleeding, pancreatic duct size, duration of intervention, type of tumor and quality of lymphatic resection). Methodology: Phase III prospective multicenter study in patients undergoing distal pancreatectomy for any origin. All consecutive patients who undergo a distal pancreatectomy for any cause in a multicenter setting will be included. A simple randomization of the participants to the RFA group or to the control group (stapler) will be carried out. The incidence of pancreatic fistula will be assessed as main variable; predictive multivariable models with multiple regression for quantitative variables, logistic regression for categorical variables and Cox regression for survival analyzes. In addition to histological study, molecular analysis of resection specimen and clinical and radiological follow-up with volumetry of necrosis in the area of post-pancreatectomy transection will be performed.

Enrollment

110 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Solid or cystic, benign or malign pancreas neoplasms.
  • Patients undergoing a distal pancreatectomy, i.e pancreas transection beyond > 2 cm from the SMV (assessed by computer tomography or RM) with or without splenectomy
  • Both open and laparoscopic approaches are valid.

Exclusion criteria

  • Patients who required a pancreatectomy with transection at the level of the neck.
  • Non-intervention group: only stapler transection will be accepted, other pancreatic transection methods will be excluded.
  • Patients ASA≥IV
  • Absence of informed consent
  • Underage (<18 years)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

110 participants in 2 patient groups

Radiofrequency-assisted
Experimental group
Treatment:
Procedure: Radiofrequency-assisted pancreas transection
Stapler
Active Comparator group
Treatment:
Procedure: Stapler assisted pancreas transection

Trial contacts and locations

1

Loading...

Central trial contact

Patricia Sánchez-Velázquez, MD PhD FEBS; Fernando Burdío, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems